Penicillin Allergy…Maybe Not? The Military Relevance for Penicillin Testing and De-labeling.


Journal

Military medicine
ISSN: 1930-613X
Titre abrégé: Mil Med
Pays: England
ID NLM: 2984771R

Informations de publication

Date de publication:
01 03 2019
Historique:
received: 02 05 2018
revised: 28 06 2018
accepted: 19 07 2018
pubmed: 24 8 2018
medline: 25 2 2020
entrez: 24 8 2018
Statut: ppublish

Résumé

Penicillin allergy is the most common drug allergy reported. About 8-10% of individuals in the USA have a documented penicillin allergy, yet 90% are not truly allergic to penicillin. A penicillin allergy "label" results in increased antibiotic-related adverse reactions and increased health care costs, thus impacting the overall "readiness" of the military. A review of the current literature and approaches to penicillin allergy and "de-labeling" a patient who reports penicillin allergy was conducted and future strategies to identify and assess military beneficiaries were outlined. Military allergists had a formal discussion at the Tri-service Military Allergy Immunology Assembly regarding the state of penicillin allergy testing in military allergy clinics. A PubMed search yielded 5,775 results for "penicillin allergy" and 484 results for "penicillin allergy testing." There were two formalized penicillin testing programs in the military treatment facilities. In 2017, the military trained nearly 165,000 new recruits. If 5-10% reported a penicillin allergy and 90% were de-labeled, that would yield a $15-30 million cost savings annually. Further, de-labeling of the 9.4 million active duty, beneficiaries and retirees with a 90% success rate could result in even greater savings for the military health care system. A penicillin allergy label is a risk to military readiness secondary to associated increases in the length of hospitalizations and emergency department and medical visits. Penicillin de-labeling is a simple intervention that can improve readiness, significantly decrease health care costs and prevent antibiotic resistance, as well as antibiotic-associated adverse events. The military allergist should be "front and center" providing expertise guidance and leadership for clinic and hospital-based penicillin de-labeling efforts which are nested within the antibiotic stewardship programs.

Identifiants

pubmed: 30137597
pii: 5077210
doi: 10.1093/milmed/usy194
doi:

Substances chimiques

Penicillins 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e163-e168

Informations de copyright

Published by Oxford University Press on behalf of the Association of Military Surgeons of the United States 2018.

Auteurs

Rachel U Lee (RU)

Naval Medical Center San Diego, Division of Allergy/Immunology, NTC Branch Health Clinic, 2051 Cushing Rd. San Diego, CA.

Taylor A Banks (TA)

Walter Reed National Military Medical Center, Division of Allergy/Immunology, 8901 Rockville Pike, Bethesda, MD.

Kirk H Waibel (KH)

Landstuhl Regional Medical Center, Allergy Service, Division of Medicine, Dr. Hitzelberger Strasse, Landstuhl, Germany.

Rechell G Rodriguez (RG)

Uniformed Services University of the Health Sciences, 4301 Jones Bridge Rd, Bethesda, MD.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH